These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30544588)

  • 1. Induced Pluripotent Stem Cells for Duchenne Muscular Dystrophy Modeling and Therapy.
    Danisovic L; Culenova M; Csobonyeiova M
    Cells; 2018 Dec; 7(12):. PubMed ID: 30544588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of Induced Pluripotent Stem Cells From Patients With Duchenne Muscular Dystrophy and Their Induction to Cardiomyocytes.
    Hashimoto A; Naito AT; Lee JK; Kitazume-Taneike R; Ito M; Yamaguchi T; Nakata R; Sumida T; Okada K; Nakagawa A; Higo T; Kuramoto Y; Sakai T; Tominaga K; Okinaga T; Kogaki S; Ozono K; Miyagawa S; Sawa Y; Sakata Y; Morita H; Umezawa A; Komuro I
    Int Heart J; 2016; 57(1):112-7. PubMed ID: 26673445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of three Duchenne muscular dystrophy patient-derived induced pluripotent stem cell (iPSC) lines ICGi002-A, ICGi002-B and ICGi002-C.
    Valetdinova KR; Maretina MA; Vyatkin YV; Perepelkina MP; Egorova AA; Baranov VS; Kiselev AV; Gershovich PM; Zakian SM
    Stem Cell Res; 2020 Oct; 48():101941. PubMed ID: 32777771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice.
    Zhang Y; Long C; Li H; McAnally JR; Baskin KK; Shelton JM; Bassel-Duby R; Olson EN
    Sci Adv; 2017 Apr; 3(4):e1602814. PubMed ID: 28439558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of two induced pluripotent stem cell (iPSC) lines from patients with Duchenne muscular dystrophy (IGIBi006-A and IGIBi008-A) carrying exonic deletions in the dystrophin gene.
    Ahmad I; Goel D; Ghosh A; Kapoor H; Kumar D; Ramesh K; Ashley B; Deepika K; Shastry A; Faruq M
    Stem Cell Res; 2022 Oct; 64():102927. PubMed ID: 36191544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell-based therapies for Duchenne muscular dystrophy.
    Sun C; Serra C; Lee G; Wagner KR
    Exp Neurol; 2020 Jan; 323():113086. PubMed ID: 31639376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro.
    Vieira NM; Brandalise V; Zucconi E; Jazedje T; Secco M; Nunes VA; Strauss BE; Vainzof M; Zatz M
    Biol Cell; 2008 Apr; 100(4):231-41. PubMed ID: 17997718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of five induced pluripotent stem cell lines with DMD/c.497G > T mutation from renal epithelial cells of a Duchenne muscular dystrophy patient and a recessive carrier parent.
    Su J; Wang J; Wang L; Li T; Wang H; Shen J; Wang H; Zhang J; Lin W; Huang J; Liang P
    Stem Cell Res; 2020 Dec; 49():102021. PubMed ID: 33039804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete restoration of multiple dystrophin isoforms in genetically corrected Duchenne muscular dystrophy patient-derived cardiomyocytes.
    Zatti S; Martewicz S; Serena E; Uno N; Giobbe G; Kazuki Y; Oshimura M; Elvassore N
    Mol Ther Methods Clin Dev; 2014; 1():1. PubMed ID: 26015941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duchenne muscular dystrophy: an updated review of common available therapies.
    Salmaninejad A; Valilou SF; Bayat H; Ebadi N; Daraei A; Yousefi M; Nesaei A; Mojarrad M
    Int J Neurosci; 2018 Sep; 128(9):854-864. PubMed ID: 29351004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of GZKHQi001-A and GZWWTi001-A, two induced pluripotent stem cell lines derived from peripheral blood mononuclear cells of Duchenne muscular dystrophy patients.
    Yuhuan X; Yingjun X; Yanting X; Yuchang C; Bing S; Shaoying L; Haoxian L; Yexing X; Shuming O; Zeyu X; Xiaofang S
    Stem Cell Res; 2018 Apr; 28():25-28. PubMed ID: 29414414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem cells from urine of Duchenne muscular dystrophy patients.
    Ghori FF; Wahid M
    Pediatr Int; 2021 Sep; 63(9):1038-1047. PubMed ID: 33599058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
    Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells.
    Shoji E; Sakurai H; Nishino T; Nakahata T; Heike T; Awaya T; Fujii N; Manabe Y; Matsuo M; Sehara-Fujisawa A
    Sci Rep; 2015 Aug; 5():12831. PubMed ID: 26290039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.
    Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP
    Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of ZZUi008-A, a transgene-free, induced pluripotent stem cell line derived from chorionic villi cells of a fetus with Duchenne muscular dystrophy.
    Zhu X; Cai A; Meng J; Liu L; Cui S; Qu S; Zhao J; Liu N; Kong X
    Stem Cell Res; 2018 Oct; 32():47-50. PubMed ID: 30172907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derivation of the Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line lacking DMD exons 49 and 50 (CCMi001DMD-A-3, ∆49, ∆50).
    Spaltro G; Vigorelli V; Casalnuovo F; Spinelli P; Castiglioni E; Rovina D; Paganini S; Di Segni M; Nigro P; Gervasini C; Pompilio G; Gowran A
    Stem Cell Res; 2017 Dec; 25():128-131. PubMed ID: 29127875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
    Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
    Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duchenne muscular dystrophy: genome editing gives new hope for treatment.
    Crispi V; Matsakas A
    Postgrad Med J; 2018 May; 94(1111):296-304. PubMed ID: 29386334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.